Study identifier:D5550C00001
ClinicalTrials.gov identifier:NCT01817569
EudraCT identifier:N/A
CTIS identifier:N/A
Specific Clinical Experience Investigation for long-term use of exenatide (Byetta subcutaneous injection)
Type 2 Diabetes
N/A
No
-
All
2948
Observational
N/A
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Jul 2020 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|---|
Byetta | - |